PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
14525968-8	2004	A suboptimal ATL146e concentration (1 nM) combined with the type IV phosphodiesterase inhibitor rolipram (100 nM) synergistically decreased stimulated CD49d expression by >50%.	ATL 146e	13-20	integrin subunit alpha 4	Homo sapiens	151-156
18757481-2	2008	Since the activation of A2A adenosine receptors (A2AARs) inhibits reperfusion injury, we hypothesized that ATL146e (a selective A2AAR agonist) might protect hearts in part by reducing cardiac mast cell degranulation.	ATL 146e	107-114	adenosine A2a receptor	Mus musculus	49-54